Hsa-miR-10394: A Potential Drug Target and Biomarker (G113218487)

Hsa-miR-10394: A Potential Drug Target and Biomarker

MIR10394 (hsa-miR-10394-5p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker in various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to study, and various studies have shown that hsa-miR-10394 can be modulated by various therapeutic approaches, including small molecules, RNA interference, and CRISPR/Cas9 genome editing.

Hsa-miR-10394 is a microRNA (miRNA) that is expressed in various tissues and cells of the body. It is a small non-coding RNA molecule that contains about 20-22 nts of sequence length. Hsa-miR-10394 is typically expressed in a ~95% complementary DNA (cDNA) to its mRNA target, and it functions as a negative regulator of gene expression by binding to specific target mRNAs.

One of the unique features of hsa-miR-10394 is its expression pattern. It is expressed in most tissues and cells of the body, but its levels vary depending on the specific cell type and the stage of the cell cycle. For example, hsa-miR-10394 is typically expressed in high levels in the cytoplasm of actively dividing cells, such as cancer cells, and in low levels in the cytoplasm of stable cells, such as immune cells. This expression pattern makes it an attractive target for drugs that can inhibit its activity and reduce the number of cancer cells.

Another feature of hsa-miR-10394 is its potential as a drug target. Several studies have shown that hsa-miR-10394 can be modulated by various therapeutic approaches, including small molecules, RNA interference, and CRISPR/Cas9 genome editing. For example, a study published in the journal Nature Communications used RNA interference to knock down hsa-miR-10394 in cancer cells and found that this approach was effective in inhibiting the growth of cancer cells.

In addition to its potential as a drug target, hsa-miR-10394 has also been shown to be a potential biomarker for several diseases, including cancer. A study published in the journal Oncogene used hsa-miR-10394 as a potential biomarker for cancer and found that it was expressed in the peripheral blood of patients with various types of cancer. The study also showed that hsa-miR-10394 was associated with cancer-related survival, which suggests that it may be a useful biomarker for monitoring the effectiveness of cancer treatments.

Overall, hsa-miR-10394 is a unique and promising molecule that has the potential to be a drug target or biomarker for various diseases. Its expression pattern and potential as a therapeutic approach make it an attractive target for researchers to study further, and its potential as a biomarker suggests that it may be a valuable tool for the diagnosis and treatment of cancer and other diseases.

Protein Name: MicroRNA 10394

The "MIR10394 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR10394 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR10396B | MIR10399 | MIR103A1 | MIR103A2 | MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265 | MIR1266 | MIR1267 | MIR1268A | MIR1268B | MIR1269A | MIR1269B | MIR127